Literature DB >> 10877008

Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers.

T Rygnestad1, K Zahlsen, F A Samdal.   

Abstract

OBJECTIVES: The aim of this study was to compare the rate of absorption between ordinary paracetamol tablets and effervescent paracetamol tablets.
METHODS: Twenty healthy volunteers participated in an open randomised crossover study and were given a 1000-mg dose of either ordinary paracetamol tablets (2 x 500 mg Panodil tablets, SmithKline Beecham) or effervescent paracetamol tablets (2 x 500 mg Pinex Brusetablett, Alpharma AS) with a 3-week washout period in between. Blood samples were collected for 3 h. Maximum serum concentration (Cmax) and the time to maximum serum concentration (tmax) were recorded and the area under the concentration versus time curve (AUC) was calculated.
RESULTS: The mean tmax was significantly shorter when paracetamol effervescent tablets were taken (27 min) rather than ordinary paracetamol tablets (45 min) (P = 0.004). There was no significant difference between the mean Cmax of 143 micromol/l with effervescent tablets and that of 131 micromol/l with ordinary tablets. The mean AUC(0-3 h) was significantly higher with paracetamol effervescent tablets (223.8 micromol x h x l(-1)) than with ordinary tablets (198.2 micromol x h x l(-1); P = 0.003). After 15 min, 17 (85%) subjects in the effervescent group had a serum concentration of 70 micromol/l (lower therapeutic serum concentration) or higher relative to only 2 (10%) subjects in the ordinary tablet group (P = 0.001).
CONCLUSION: Paracetamol effervescent tablets are absorbed significantly faster than ordinary paracetamol. Thus, effervescent tablets might offer significantly faster pain relief when paracetamol is used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877008     DOI: 10.1007/s002280050732

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

Review 1.  The use of opioids in the treatment of osteoarthritis: when, why, and how?

Authors:  Jeremy L R Goodwin; Jan J Kraemer; Zahid H Bajwa
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

2.  A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions.

Authors:  Stéphanie Blanquet; Evelijn Zeijdner; Erick Beyssac; Jean-Philippe Meunier; Sylvain Denis; Robert Havenaar; Monique Alric
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

3.  A new high-absorption-rate Paracetamol 500-mg formulation: a comparative bioavailability study in healthy volunteers.

Authors:  Antonio Portolés; Miguel Puerro; Ana Terleira; Angel Rodríguez; Maria-Cruz Caturla; Nieves Fernández; Emilio Vargas
Journal:  Curr Ther Res Clin Exp       Date:  2003-07

Review 4.  Paracetamol: a focus for the general pediatrician.

Authors:  Pierluigi Marzuillo; Stefano Guarino; Egidio Barbi
Journal:  Eur J Pediatr       Date:  2013-12-28       Impact factor: 3.183

Review 5.  The use of opioids in the treatment of osteoarthritis: when, why, and how?

Authors:  Jeremy L R Goodwin; Jan J Kraemer; Zahid H Bajwa
Journal:  Curr Pain Headache Rep       Date:  2005-12

6.  Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes.

Authors:  Marlon J A Jetten; Ainhoa Ruiz-Aracama; Maarten L J Coonen; Sandra M Claessen; Marcel H M van Herwijnen; Arjen Lommen; Joost H M van Delft; Ad A C M Peijnenburg; Jos C S Kleinjans
Journal:  Arch Toxicol       Date:  2015-06-24       Impact factor: 5.153

7.  Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers.

Authors:  Nora Angélica Núñez Guzmán; Daniel Ruiz Molina; Benigno Figueroa Núñez; Juan Carlos Soto-Sosa; Jorge Eduardo Herrera Abarca
Journal:  Drugs R D       Date:  2016-12

8.  Comparative study between paracetamol and two different doses of pregabalin on postoperative pain in laparoscopic cholecystectomy.

Authors:  Ibrahim M Esmat; Hanan M Farag
Journal:  Saudi J Anaesth       Date:  2015 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.